Contents
Heart disease symptoms in women are not always dramatic or easy to recognize. Chest pain or discomfort remains the most common heart attack symptom in women, but some women experience pressure, tightness, unusual fatigue, shortness of breath, nausea, dizziness, upper-back pain, jaw discomfort, or symptoms that resemble indigestion.
These symptoms may be mistaken for stress, anxiety, a respiratory illness, acid reflux, menopause, poor sleep, or the demands of everyday life. Symptoms reported by younger women may also be attributed to noncardiac causes before heart disease is fully considered.
Recognizing warning signs is only one part of protecting women’s heart health. Blood pressure, cholesterol, blood sugar, kidney function, inflammation, inherited lipid risk, pregnancy history, menopause, autoimmune disease, smoking, and family history can all contribute to cardiovascular risk.
Ulta Lab Tests provides direct access to many laboratory tests that can help women examine these risk factors. However, routine laboratory testing cannot determine whether someone experiencing sudden symptoms is having a heart attack. Acute symptoms require immediate medical evaluation.

Medical and emergency disclaimer: Call 911 for new, severe, persistent, or worsening chest pressure; difficulty breathing; fainting; cold sweats; sudden weakness; or pain spreading to the arm, back, neck, jaw, or upper abdomen. Do not delay emergency care to order outpatient laboratory testing.
Read: Women’s Heart Disease – Why Guidelines Still Fail → Women’s Heart Disease: Why Guidelines Still Fail – Even when women have risk factors and symptoms, they’re often underdiagnosed. Explore how male-centered heart guidelines, outdated biomarker cutoffs, and overlooked female risk factors contribute to missed heart disease in women—and how advanced lab panels can change that.
Heart disease is a broad term for conditions affecting the heart, coronary arteries, small blood vessels, heart muscle, valves, rhythm, or pumping function. Women can develop the same major heart conditions as men, but their symptoms, risk patterns, and underlying disease may not always look identical.
Coronary artery disease develops when blood flow through the arteries supplying the heart becomes limited. This may occur because of plaque buildup in larger coronary arteries, dysfunction in the smaller vessels, vessel spasms, blood clots, or other vascular problems.
Coronary microvascular disease affects the small vessels within the heart and is more common in women. Women are also more likely than men to experience certain heart attacks without a major obstructive blockage in a large coronary artery. These differences can make evaluation more complex, particularly when symptoms are not accompanied by a familiar pattern of crushing chest pain.
Heart disease can also include:
Symptoms alone cannot identify which condition is present. Clinical history, physical examination, blood pressure, electrocardiography, imaging, and appropriately selected laboratory tests may all contribute to an evaluation.

Heart disease remains the leading cause of death among women in the United States. Some women have no noticeable symptoms before a cardiovascular event, while others experience signs that are mild, intermittent, or attributed to another cause.
An important misconception is that women usually do not experience chest pain during a heart attack. In reality, chest pain or discomfort is still the most common symptom in women. The difference is that women may also report symptoms such as nausea, unusual tiredness, breathlessness, shoulder or back pain, dizziness, or anxiety.
Long-term cardiovascular risk can also change across a woman’s life. Pregnancy complications may reveal an underlying tendency toward high blood pressure, insulin resistance, diabetes, vascular dysfunction, or kidney disease. Menopause may coincide with changes in cholesterol, body-fat distribution, blood pressure, glucose regulation, and vascular health.
Pregnancy-related hypertension, preeclampsia, gestational diabetes, preterm delivery, and other adverse pregnancy outcomes are associated with greater cardiovascular risk later in life. Early or premature menopause can also be a cardiovascular risk-enhancing factor.

| Symptom or Warning Sign | What It May Suggest | Tests or Evaluation That May Help |
|---|---|---|
| Chest pressure, tightness, fullness, burning, heaviness, or pain | Reduced blood flow to the heart, acute coronary syndrome, or another cardiac or noncardiac cause | Immediate clinical evaluation, ECG, serial troponin testing, and imaging when indicated |
| Shortness of breath | Heart ischemia, heart failure, anemia, lung disease, infection, or other causes | Urgent assessment if sudden; Complete Blood Count with Differential and Platelets, Comprehensive Metabolic Panel, NT-proBNP Test, ECG, and imaging when clinically appropriate |
| Unusual or overwhelming fatigue | Possible heart disease, anemia, thyroid dysfunction, infection, sleep problems, or metabolic illness | Complete Blood Count with Differential and Platelets, Ferritin Test, TSH Test, Comprehensive Metabolic Panel, glucose testing, and Hemoglobin A1c Test |
| Jaw, neck, shoulder, back, or arm discomfort | Referred cardiac discomfort or musculoskeletal, neurologic, or digestive causes | Urgent medical evaluation when new, unexplained, or associated with breathlessness, sweating, weakness, or nausea |
| Nausea, vomiting, heartburn, or upper-abdominal discomfort | Possible cardiac symptoms, gastrointestinal illness, medication effects, or other causes | Emergency evaluation when sudden or combined with chest pressure, sweating, weakness, or breathlessness |
| Dizziness, lightheadedness, or fainting | Rhythm disturbance, reduced blood flow, blood-pressure changes, anemia, dehydration, or metabolic problems | ECG, vital signs, Complete Blood Count with Differential and Platelets, Comprehensive Metabolic Panel, and glucose testing |
| Cold sweat or unexplained clamminess | Acute physiologic stress, including a possible heart attack | Call 911 when sudden or accompanied by chest or upper-body discomfort |
| Palpitations or an irregular heartbeat | Arrhythmia, thyroid dysfunction, anemia, electrolyte disturbance, anxiety, or stimulant exposure | ECG or rhythm monitoring; TSH Test, Complete Blood Count with Differential and Platelets, and Comprehensive Metabolic Panel when appropriate |
| Swelling in the legs, ankles, or abdomen | Fluid retention, heart failure, kidney disease, venous disease, or medication effects | Clinical examination, Comprehensive Metabolic Panel, kidney testing, Albumin Random Urine Test with Creatinine, and NT-proBNP Test when indicated |
| Reduced exercise tolerance | Heart, lung, blood, metabolic, or conditioning-related causes | Clinical evaluation; Complete Blood Count with Differential and Platelets, Ferritin Test, Comprehensive Metabolic Panel, TSH Test, Hemoglobin A1c Test, lipid testing, ECG, or clinician-directed stress testing |
Call 911 immediately for:
Acute coronary syndrome includes heart attack and unstable angina. It occurs when the heart muscle suddenly receives inadequate blood flow and requires immediate medical care.

Traditional cardiovascular risks affect women and men, but several factors may be especially relevant during a woman’s lifetime.
A complete women’s heart-health history should also consider:
Pregnancy may function as an early cardiovascular stress test. Women who develop hypertension, preeclampsia, or gestational diabetes during pregnancy may require continued attention to blood pressure, glucose, cholesterol, kidney health, and other cardiovascular risk factors after pregnancy.
Laboratory testing can help identify cardiovascular risk factors and conditions that may mimic or worsen heart-related symptoms. It cannot independently diagnose coronary artery disease or rule out an active heart attack.

Blood and urine tests may provide information about:
Routine outpatient blood tests cannot directly show:
A suspected heart attack is evaluated with symptoms, medical history, an electrocardiogram, serial cardiac troponin measurements, and other appropriate tests. Troponin may need to be repeated because its concentration changes over time.
| Laboratory Test | What It Measures | Why It May Matter | General Interpretation and Limitations |
|---|---|---|---|
| Lipid Panel Test | Total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides | Establishes a foundational view of lipid-related cardiovascular risk | Higher LDL cholesterol or triglycerides may increase concern, but normal values do not eliminate cardiovascular risk. |
| Apolipoprotein B Test | ApoB carried on atherogenic cholesterol-containing particles | May reveal a high number of potentially artery-entering particles when LDL cholesterol alone appears less concerning | May be particularly useful for people with diabetes, metabolic syndrome, elevated triglycerides, or differences between LDL cholesterol and overall risk. |
| Lipoprotein (a) Test | Genetically influenced lipoprotein(a), or Lp(a), particles | Helps identify inherited cardiovascular risk that is not included in a standard lipid panel | Lp(a) is usually relatively stable over time. An elevated result adds risk information but does not prove that cardiovascular disease is present. |
| High-Sensitivity C-Reactive Protein Test | Low concentrations of C-reactive protein | May help assess inflammatory cardiovascular risk in selected adults | Infection, injury, autoimmune activity, recent illness, and other sources of inflammation can elevate the result. |
| Hemoglobin A1c Test | Average glucose exposure over approximately two to three months | Helps identify diabetes, prediabetes, or glucose dysregulation that may affect cardiovascular risk | Anemia, altered red-cell turnover, pregnancy, and certain medical conditions can affect interpretation. |
| Comprehensive Metabolic Panel | Glucose, creatinine, electrolytes, liver markers, calcium, and proteins | Provides metabolic, kidney, liver, and electrolyte context | The CMP is a broad health panel rather than a specific heart disease test. |
| Albumin Random Urine Test with Creatinine | Urine albumin relative to urine creatinine | May identify kidney or small-vessel damage associated with higher cardiovascular risk | Exercise, urinary infection, menstruation, fever, and temporary illness may affect results. Repeat testing may be needed. |
| Complete Blood Count with Differential and Platelets | Red blood cells, hemoglobin, white blood cells, and platelets | Helps evaluate anemia and other conditions that can contribute to fatigue, dizziness, weakness, or breathlessness | A CBC cannot determine whether symptoms are being caused by heart disease. |
| Ferritin Test | Stored iron | May help evaluate iron deficiency in women with fatigue, breathlessness, heavy menstrual bleeding, or low hemoglobin | Ferritin may rise during infection or inflammation and should be interpreted with a CBC and other iron markers. |
| TSH Test | Thyroid-stimulating hormone | Thyroid dysfunction can contribute to fatigue, palpitations, weight changes, blood-pressure changes, or abnormal cholesterol | An abnormal TSH result may require additional thyroid testing and clinical evaluation. |
| NT-proBNP Test | A peptide released when the heart experiences increased wall stress | May help evaluate possible heart failure in a person with compatible symptoms | Age, kidney function, body composition, rhythm disorders, and other factors affect results. It is not a universal screening test. |
| Lipoprotein Fractionation, NMR with Lipid Panel | Lipoprotein particle concentrations and characteristics in addition to standard lipid markers | May provide additional information when standard lipid results and metabolic risk do not appear to align | Not everyone needs advanced particle testing. Results should be interpreted in the context of the person’s complete risk profile. |
A troponin test is not an appropriate substitute for emergency evaluation. Troponin is used when heart-muscle injury is suspected and is normally interpreted alongside symptoms, ECG findings, physical examination, imaging when needed, and repeated measurements.
A normal outpatient troponin result obtained at the wrong time cannot safely rule out a heart attack. Anyone with possible acute coronary symptoms should call 911 rather than travel to a routine laboratory collection location.
Testing should be selected according to age, symptoms, family history, pregnancy history, existing conditions, medications, and previous results. Not every woman needs every test.
A foundational laboratory review may include:
This level may be reasonable for preventive screening, establishing a cardiovascular baseline, or periodic monitoring directed by a healthcare provider.
Additional testing may include:
This level may be worth discussing for women with a strong family history, premature cardiovascular disease in a close relative, diabetes, metabolic syndrome, kidney disease, high triglycerides, pregnancy-related risk factors, early menopause, or unexplained differences between standard lipid results and overall cardiovascular risk.
For persistent fatigue, palpitations, exercise intolerance, dizziness, or breathlessness, a healthcare provider may consider:
These tests may help identify contributing or alternative explanations for symptoms, but they do not replace cardiac examination, electrocardiography, imaging, or emergency evaluation.
Sudden or concerning symptoms may require:
These evaluations should be performed in a medically supervised setting.
A woman may consider discussing cardiovascular laboratory testing with a healthcare provider when she:
Preventive testing should never delay urgent medical care for active warning signs.
A laboratory reference range generally describes results found in a comparison population. A value outside the range does not automatically establish disease, and a value inside the range does not guarantee that cardiovascular risk is low.
A laboratory reference interval may differ from a healthcare provider’s prevention or treatment goal. For example, an LDL cholesterol result can fall within the laboratory’s reported range yet remain above the goal selected for someone with diabetes, known cardiovascular disease, kidney disease, elevated Lp(a), or another major risk factor.
Interpretation may be affected by:
A single mildly abnormal result may be temporary. Conversely, several values that are technically within range may form a concerning pattern when considered together. Examples include rising A1c, increasing triglycerides, increasing ApoB, reduced kidney filtration, or persistent urine albumin.
Results should be reviewed with a qualified healthcare provider who can consider symptoms, blood pressure, medical history, reproductive history, family history, medications, physical findings, and imaging results.
Preparation requirements depend on the tests selected.
Testing frequency should be individualized. Some inherited markers, such as lipoprotein(a), may be measured once for an initial risk assessment, while cholesterol, glucose, kidney markers, or treatment-related tests may be repeated more frequently.
Ulta Lab Tests allows patients to order many laboratory tests directly online where available. Patients can review pricing before ordering, visit a participating laboratory location for specimen collection, and access results securely through an online account.
Testing is performed through established laboratory networks such as Quest Diagnostics where applicable. Insurance is not required to order, and eligible purchases may be paid with HSA or FSA funds, subject to the terms of the patient’s plan.
Direct access to testing can help patients:
Ulta Lab Tests does not replace emergency services, a physical examination, diagnostic imaging, or individualized medical care. Laboratory results should be shared with a qualified healthcare provider.
Chest pain or discomfort remains the most common heart attack symptom in women. Other possible symptoms include shortness of breath, unusual fatigue, nausea, vomiting, dizziness, cold sweating, and discomfort in the back, shoulder, arm, neck, jaw, or upper abdomen. A new combination of symptoms may be more concerning than any single symptom by itself.

Yes. Some women experience mild pressure, tightness, burning, fullness, or discomfort rather than severe pain. Others may notice breathlessness, nausea, back or jaw discomfort, sweating, or unusual fatigue. The absence of dramatic chest pain does not make the symptoms safe to ignore. Sudden or worsening symptoms require urgent evaluation.
Unusual fatigue can occur before or during a cardiac event, particularly when it is new, severe, unexplained, or associated with reduced exercise tolerance, chest discomfort, nausea, sweating, or breathlessness. Fatigue also has many noncardiac causes, including anemia, iron deficiency, thyroid disease, infection, poor sleep, and medication effects.
Common tests include a Lipid Panel Test, Apolipoprotein B Test, Lipoprotein (a) Test, High-Sensitivity C-Reactive Protein Test, Hemoglobin A1c Test, kidney-function markers, and Albumin Random Urine Test with Creatinine. These tests assess risk factors but do not show whether an artery is currently blocked.
No. A routine lipid panel is important, but it does not measure every source of cardiovascular risk. Some people have elevated ApoB particle numbers, high inherited Lp(a), diabetes, inflammation, kidney disease, hypertension, microvascular dysfunction, or existing arterial plaque despite an LDL cholesterol value that does not appear markedly elevated.
Current cardiovascular guidance supports measuring lipoprotein(a) at least once during adulthood. Testing may be especially informative when there is premature heart disease in the family, familial hypercholesterolemia, unexplained cardiovascular disease, or cardiovascular risk that appears greater than routine cholesterol results suggest. Results should be interpreted with the complete cardiovascular profile.
Many preventive and cardiovascular-risk tests can be ordered directly through Ulta Lab Tests where direct-access testing is available. These tests can provide information about cholesterol, blood sugar, inflammation, kidney function, anemia, thyroid function, and inherited lipid risk. They are not substitutes for emergency evaluation, an ECG, imaging, or individualized medical advice.
No. Troponin is primarily used to evaluate possible injury to the heart muscle. When a heart attack is suspected, troponin is usually measured in a hospital or emergency setting and repeated over time. Ordering a single outpatient troponin test should never delay emergency care or be used to reassure someone experiencing acute symptoms.
Preeclampsia, gestational hypertension, gestational diabetes, preterm delivery, and related complications can identify women with a greater long-term likelihood of hypertension, diabetes, kidney disease, heart failure, stroke, or coronary disease. Women should include their complete pregnancy history when discussing cardiovascular risk, even when the pregnancy occurred many years earlier.
The interval depends on age, previous results, medications, pregnancy history, family history, and existing health conditions. Some women may need periodic lipid, glucose, or kidney testing, while others require closer monitoring. Lipoprotein(a) is largely inherited and often does not require frequent repetition. A healthcare provider can recommend an individualized schedule.
Heart disease symptoms in women may include more than severe chest pain. Pressure, tightness, breathlessness, nausea, unusual fatigue, dizziness, sweating, or discomfort in the jaw, back, shoulder, arm, or upper abdomen can also signal a possible heart problem.
Recognizing urgent symptoms can save critical time. Call 911 when symptoms are sudden, persistent, severe, or associated with breathing difficulty, fainting, sweating, weakness, or spreading upper-body discomfort.
Outside an emergency, laboratory testing can help women better understand cholesterol, lipoprotein particles, inherited Lp(a), blood sugar, inflammation, kidney health, anemia, iron status, and thyroid function. These results may provide valuable context for a more complete cardiovascular-risk discussion.
Explore Heart and Cardiovascular Tests from Ulta Lab Tests to learn about available testing options. Review all results with a qualified healthcare provider who can connect the numbers with your symptoms, medical history, reproductive history, blood pressure, medications, and other clinical findings.
Heart disease symptoms in women can include chest pressure or discomfort, shortness of breath, unusual fatigue, nausea, dizziness, sweating, and pain in the jaw, back, shoulder, arm, or upper abdomen. Chest discomfort remains the most common heart attack symptom, but women may also experience less familiar warning signs that can be mistaken for noncardiac conditions.
Related laboratory tests: Lipid Panel Test, Apolipoprotein B Test, Lipoprotein (a) Test, High-Sensitivity C-Reactive Protein Test, Hemoglobin A1c Test, Comprehensive Metabolic Panel, Complete Blood Count with Differential and Platelets, Ferritin Test, TSH Test, Albumin Random Urine Test with Creatinine, NT-proBNP Test, and Lipoprotein Fractionation, NMR with Lipid Panel.
Ulta Lab Tests helps patients access many preventive and cardiovascular-risk laboratory tests directly online, with transparent pricing and secure online results.
Laboratory testing provides health information but does not replace emergency care, medical diagnosis, or review by a qualified healthcare provider.</p
These Ulta Lab Tests pages cover standard cholesterol measurements, ApoB particle burden, inherited Lp(a), and advanced NMR lipoprotein analysis.
The hs-CRP product page is available directly through Ulta Lab Tests.
These tests provide information about longer-term glucose exposure and broader metabolic, kidney, liver, and electrolyte markers.
The urine albumin-to-creatinine test provides kidney and small-vessel health information, while the CMP includes creatinine and other metabolic markers.
These tests support evaluation of anemia, blood-cell health, and stored iron when symptoms include fatigue, weakness, dizziness, or shortness of breath.
The TSH test helps assess thyroid function when symptoms such as fatigue, palpitations, weight changes, or abnormal cholesterol need additional context.
NT-proBNP is discussed in the article as a clinician-directed test that may provide information about cardiac wall stress in patients with compatible symptoms.

Ulta Lab Tests, LLC.
9237 E Via de Ventura, Suite 220
Scottsdale, AZ 85258
480-681-4081
(Toll Free: 800-714-0424)